Sapio Sciences has partnered with consulting and technology firm ZS to support the deployment of digital laboratory systems across biopharma research, development and manufacturing environments.

Under the agreement, ZS has joined the Sapio Partner Program as a consulting partner and will provide implementation and advisory services for organisations adopting the Sapio Platform across research and development and chemistry, manufacturing and controls (CMC) operations.

The companies said the partnership is designed to combine Sapio’s laboratory informatics technology with ZS’s consulting and systems integration expertise to help biopharma organisations modernise laboratory workflows and improve the management of scientific data.

The collaboration will focus on helping laboratories establish AI-ready and traceable data environments while maintaining regulatory compliance and human oversight of scientific processes.

Mike Hampton, chief commercial officer at Sapio Sciences, said: “Biopharma organizations are investing heavily in digital laboratories, particularly across development and CMC environments where data integrity and operational coordination are critical.

“Partnering with ZS gives our customers access to deep life sciences consulting and systems integration expertise and through ZS’s global network, and helps us reach more organizations undertaking that journey.”

According to the companies, customers using the Sapio Platform will be able to access ZS support throughout implementation programmes, including solution architecture, system integration, change management and user adoption.

The partnership will cover laboratory digitalisation initiatives across research and discovery, development and manufacturing, and laboratory informatics infrastructure.

Areas of focus include integrating laboratory workflows with enterprise data environments, connecting laboratory systems with quality and regulatory functions, and creating data architectures designed to support analytics and artificial intelligence applications.

Rohan Fernando, managing principal, life sciences R&D and medical at ZS, said: “The need for results in R&D is extreme: speed, lower costs and higher success rates. ELN and LIMS systems are critical as modern science depends on AI-ready, traceable lab data to enable more effective collaboration and orchestration.”

Laboratory informatics platforms have become an increasingly important component of pharmaceutical research and manufacturing operations as companies seek to improve data accessibility, automate workflows and prepare scientific datasets for AI-driven analysis.

The partnership reflects wider industry efforts to modernise laboratory infrastructure and address growing demand for connected data environments that support research, development and manufacturing activities across the drug development lifecycle.